°Ë»ö
ä¿ë
Á¤º¸
    ³ë¹ÙƼ½º 'Å×±×·¹ÅçÁ¤200mg', ¼öÀÔ¾÷¹«Á¤Áö 1°³¿ù
    ±â»çÀÔ·Â : 12.05.25 11:36:47
    0 °¡
    ÇÃÄ£Ãß°¡
    º¯°æÇã°¡ ¾øÀÌ Æ÷ÀåÀçÁú ¹Ù²ã ¼öÀÔ



    ³ë¹ÙƼ½º '#Å×±×·¹ÅçÁ¤200mg'ÀÌ ¼öÀÔ¾÷¹«Á¤Áö 1°³¿ù óºÐÀ» ¹Þ¾Ò´Ù.

    ½Ä¾àûÀº Å×±×·¹ÅçÁ¤À» ¼öÀÔÇÔ¿¡ ÀÖ¾î Çã°¡»çÇ× µî¿¡ ´ëÇÑ º¯°æ¾øÀÌ Æ÷ÀåÀçÁúÀ» º¯°æÇØ ¼öÀÔ¡¤ÆÇ¸ÅÇØ ¼öÀÔ¾÷¹«Á¤Áö 1°³¿ù óºÐÀ» ³»·È´Ù°í ¹àÇû´Ù.

    óºÐÀÏÀº ³»´Þ 1ÀϺÎÅÍ 30ÀϱîÁö´Ù.
    X
    AD
    ½ÉÆ÷Áö¾ö ´Ù½Ãº¸±â À̺¥Æ®Âü¿© ¡æ
    ÃÖºÀ¿µ ±âÀÚ(bychoi@dailypharm.com)
    ±ÛÀÚÅ©±â ¼³Á¤
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    °¡³ª´Ù¶ó¸¶¹Ù»ç
    • º»»ç Medical Affairs ä¿ë(°ø°í¿¬Àå) ¹Ù·Î°¡±â
    • ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë(¾à»ç) ¹Ù·Î°¡±â
    • [Á¦¾à»ç¾÷ºÎ¹®] °³¹ßÆÀ(RA) ¾à»ç ½ÅÀÔ/°æ·Â ä¿ë ¹Ù·Î°¡±â
    • °­¸ª°øÀå Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â
    • ¼­¿ïƯº°½Ã Á¾·Î±¸ ÀÓ±âÁ¦°ø¹«¿ø(¾à»ç) ÀÓ¿ë°èȹ Àç°ø°í ¹Ù·Î°¡±â
    • [¾à»ç »ý»êº»ºÎÀå:°øÀåÀå]´ëÇüÄÚ½ºÇÇÁ¦¾à»ç(´ëÀü) ¹Ù·Î°¡±â
    • Senior Associate, PV (Pharmacovigilance) ¹Ù·Î°¡±â
    • RA Assistant Specialist (Contract) ½ÅÀÔ °¡´É ¹Ù·Î°¡±â
    • °æ³² ÇԾȰøÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â
    • Çѱ¹¿¡ÀÚÀÌ Market Access Leader ä¿ë ¹Ù·Î°¡±â
    • Á¤±ÔÁ÷ ¾à¹«Á÷(ÆÀÀå) ¾à»ç ä¿ë °ø°í ¹Ù·Î°¡±â
    • [Çѵ¶] MA, Àü¹®ÀǾàǰ/ÀϹÝÀǾàǰ ¸¶ÄÉÆÃ, ÇØ¿Ü¿µ¾÷, CRA, ÀÇ·á±â±â Service Business, ¾à»ç, ±â¼úÆÀ ±³Á¤´ã´ç, Çѵ¶ÇコÄÉ¾î °æ¿µ°ü¸®,Ãѹ« ÆÀÀå ¹Ù·Î°¡±â
    • 2025³â Á¦3Â÷ Á÷¿øÃ¤¿ë ¿¬Àå°ø°í ¹Ù·Î°¡±â
    • MCE Strategy & Operations Specialist (»êÈÞ´ëü ÆÄ°ßÁ÷) ¹Ù·Î°¡±â
    • ¿ëÀÎ ¹é¾Ï°øÀå ǰÁú°ü¸® ¾à»ç ä¿ë(½ÅÀÔ/°æ·Â) ¹Ù·Î°¡±â
    • ÃæºÏ À½¼º Á¦Á¶°ü¸®¾à»ç °æ·Â¹«°ü ¹Ù·Î°¡±â
    0/300
     
    ¸ÞÀϺ¸³»±â
    ±â»çÁ¦¸ñ : ³ë¹ÙƼ½º Å×±×·¹ÅçÁ¤200mg, ¼öÀÔ¾÷¹«Á¤Áö 1°³¿ù